MetLife Investment Management’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $180K | Hold |
|
|||||
|
2025
Q2 | $110K | Hold |
|
|||||
|
2025
Q1 | $113K | Sell |
|
|||||
|
2024
Q4 | $172K | Hold |
|
|||||
|
2024
Q3 | $132K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $80.5K | Sell |
|
|||||
|
2023
Q4 | $103K | Hold |
|
|||||
|
2023
Q3 | $87K | Hold |
|
|||||
|
2023
Q2 | $124K | Hold |
|
|||||
|
2023
Q1 | $141K | Hold |
|
|||||
|
2022
Q4 | $138K | Hold |
|
|||||
|
2022
Q3 | $148K | Hold |
|
|||||
|
2022
Q2 | $176K | Hold |
|
|||||
|
2022
Q1 | $255K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $106K | Buy |
|